
Wednesday, March 10, 2010
Bruker acquires products from Agilent's Varian
By Mass High Tech staff
Medical technologies developer Bruker Corp. has signed an asset purchase agreement with California genomics research firm Agilent Technologies Inc. to buy several product lines of Varian Inc.
The product lines include the Melbourne, Australia-based business of inductively coupled plasma mass spectrometry instruments; laboratory gas chromatography instruments, based in the Netherlands; and the gas chromatography triple-quadruple mass spectrometry instruments business in Walnut Creek, California.
The deal calls for Bruker to continue operating these businesses and to retain key personnel for the management, operations, research, marketing and sales within the businesses.
“These three businesses offer an opportunity to leverage our existing strengths in the analytical instruments market,” said Frank Laukien, president and CEO of Bruker, in a press release. “The three new product lines will form the core offerings in a newly established Bruker Chemical Analysis Division.”
Agilent’s acquisition of the Varian lines requires the divestiture of certain product lines, according to the press release.
No financial terms of the acquisition deal were disclosed.
Billerica-based Bruker (Nasdaq:BRKR) develops and manufactures X-ray technologies, magnetic resonance technologies, mass spectrometry technologies, optical emission spectroscopy and infrared and Raman molecular spectroscopy technologies for the life science, pharmaceutical, biotechnology and molecular diagnostics industries.
Comments
If you are commenting using a Facebook account, your profile information may be displayed with your comment depending on your privacy settings. By leaving the 'Post to Facebook' box selected, your comment will be published to your Facebook profile in addition to the space below.

Print
Email
Print Edition Stories



